AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 405408
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) 4% solution instilled into each eye 4 times daily
Trial: 28107729
Drug: Recombinant LH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant LH (rLH) supplementation (75 IU daily from day 7 of FSH stimulation to the day of HCG trigger)
Trial: 23608774
Drug: Levobupivacaine 0.25%
RxNorm normalized name: levobupivacaine 0.25% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.25% 1 ml/kg plus sufentanil 0.5 μg/kg (Group LS)
Trial: 23608774
Drug: Levobupivacaine 0.25%
RxNorm normalized name: levobupivacaine 0.25% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.25% 1 ml/kg only (Group L)
Trial: 12005088
Drug: q48h dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: q48h dosing schedule (5.0 or 4.5 mg/kg/dose q48h)
Trial: 12005088
Drug: q24h dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: q24h dosing schedule (2.5 or 3.0 mg/kg/dose q24h)
Trial: 12005088
Drug: q48h dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: q48h dosing schedule
Trial: 12005088
Drug: q24h dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: q24h dosing schedule
Trial: 2550335
Drug: Kabi 2165
RxNorm normalized name: immunoglobulin G, human Injectable Solution [Kabiglobulin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kabi 2165 (low-molecular-weight heparin) 2 X 2,500 anti-Xa units s.c.
Trial: 1098181
Drug: Parenteral administration
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral administration of cephradine
Trial: 1098181
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of cephradine
Trial: 29941500
Drug: Metformin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin alone for 12 months
Trial: 31178434
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine for 3 months followed by metformin for 9 months
Trial: 31178434
Drug: Liraglutide combined
RxNorm normalized name: Liraglutide
DrugBank: Liraglutide (DB06655)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liraglutide combined with metformin for 12 months
Trial: 25291499
Drug: Dutasteride (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (0.5 mg daily for 8 weeks)
Trial: 18465191
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) after subgingival scaling and root planing
Trial: 14971587
Drug: Levodopa (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (2 mg/kg body weight)
Trial: 8751022
Drug: 4% erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% erythromycin plus 1.2% zinc (Zineryt lotion)
Trial: 8751022
Drug: 4% erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% erythromycin lotion (control)
Trial: 90768
Drug: Concurrent induced-abortion/sterilisation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent induced-abortion/sterilisation group
Trial: 26564297
Drug: Sugammadex (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (2 mg/kg intravenously)
Trial: 26564297
Drug: Neostigmine/atropine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine/atropine combination (0.05 mg/kg neostigmine and 0.02 mg/kg atropine)
Trial: 16600415
Drug: Sequential changes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential changes in fasting plasma glucose (FPG) levels within the normoglycemic range (FPG<100 mg/dl)
Trial: 8132365
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg once daily for 10 days
Trial: 8132365
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 1 million U three times daily for 10 days
Trial: 19336502
Drug: Placebo added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo added to aspirin
Trial: 27596801
Drug: Probiotic group
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic group (n=10) received Lactobacillus rhamnosus SP1 at a dose of 3×10^9 cfu/day (75 mg/day)
Trial: 22385118
Drug: Gonadotropin treatment
RxNorm normalized name: Chorionic Gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropin treatment (GnTh) using β Human Chorionic Gonadotropin (β HCG) and Follicle Stimulating Hormone (FSH) for up to 30 months.
Trial: 12475576
Drug: Dinoprostone 0.5
RxNorm normalized name: dinoprostone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone 0.5 mg doses given intra-cervically every 6 h
Trial: 10391423
Drug: Monitoring with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monitoring with antifactor Xa heparin activity (HA)
Trial: 8655902
Drug: Fortified formula
RxNorm normalized name: B-Complex Fortified Formula Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified formula (alpha-linolenic acid 1.8 g/day, arginine 7.8 g/day, RNA 0.75 g/day)
Trial: 12462952
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement 'ExPress'
Trial: 2684078
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin (750 mg every 12 hours)
Trial: 2684078
Drug: Intravenous cefotaxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cefotaxime (2.0 g every 8 hours)
Trial: 240378
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg oral dose)
Trial: 23869185
Drug: Remifentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil at infusion rate of 0.1 μg·kg(‐1)·min(‐1) (Group L)
Trial: 23869185
Drug: Remifentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil at infusion rate of 0.5 μg·kg(‐1)·min(‐1) (Group H)
Trial: 21047149
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment for opioid dependence
Trial: 15022297
Drug: Accelerated radiotherapy
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated radiotherapy with carboplatin chemotherapy
Trial: 15022297
Drug: Conventional radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional radiotherapy with carboplatin chemotherapy
Trial: 15022297
Drug: Radiotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy without carboplatin chemotherapy
Trial: 11750220
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GR‐1/Lactobacillus fermentum RC‐14 (once and twice daily)
Trial: 8000301
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of beta-carotene (BC) daily for 3 months
Trial: 2725335
Drug: Nomegestrol acetate
RxNorm normalized name: nomegestrol acetate
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol acetate 0.5 mg daily
Trial: 2725335
Drug: Nomegestrol acetate
RxNorm normalized name: nomegestrol acetate
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol acetate 1.0 mg daily
Trial: 2725335
Drug: Nomegestrol acetate
RxNorm normalized name: nomegestrol acetate
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol acetate 2.5 mg daily
Trial: 2725335
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oestrogen therapy only)
Trial: 781439
Drug: 410 mg
RxNorm normalized name: aspirin 410 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 410 mg of prednisone plus vitamins in descending doses over 10 days
Trial: 20105150
Drug: Propofol target
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target controlled infusion
Trial: 17481578
Drug: High chronic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High chronic stress group (post hoc division based on chronic daily stress questionnaire)
Trial: 17481578
Drug: Low chronic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low chronic stress group (post hoc division based on chronic daily stress questionnaire)
Trial: 2342818
Drug: Oral immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunization with inactivated influenza vaccine (Mississippi 1/85; dosage: 110 micrograms HA)
Trial: 31498862
Drug: Papaverine injection
RxNorm normalized name: papaverine Injection
DrugBank: Papaverine (DB01113)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Papaverine injection (0.1 or 0.2 cc)
Trial: 31498862
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine AVF construction without papaverine injection)
Trial: 19171333
Drug: prolonged GnRHa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prolonged GnRHa (depot leuprolide acetate 3.75 mg every 28 days for three doses)
Trial: 16716615
Drug: memantine (20-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: memantine (20-30 mg daily, n=10)
Trial: 2385207
Drug: Preoperative intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative intravenous infusion of 10 mg of Propionibacterium avidum KP-40
Trial: 2385207
Drug: Postoperative re-infusion
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative re-infusion of Propionibacterium avidum KP-40
Trial: 6156361
Drug: Minoxidil in
RxNorm normalized name: Product containing minoxidil in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minoxidil in combination with propranolol at a dosage ratio of 1:8
Trial: 6156361
Drug: Minoxidil in
RxNorm normalized name: Product containing minoxidil in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minoxidil in combination with propranolol at dosage ratios of 1:2 and 1:4
Trial: 25882910
Drug: Low-dose LPS
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose LPS (0.4 ng/kg body weight)
Trial: 21535913
Drug: Grass MATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass MATA MPL (300-2000 standardized units/injection)
Trial: 14727971
Drug: Percutaneous myocardial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous myocardial revascularization (PMR) plus medical therapy
Trial: 8553675
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II induced hypertension chemotherapy (IHC)
Trial: 105101
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg daily for 3 days at the onset of symptoms)
Trial: 12715685
Drug: Nicergoline (Adavin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicergoline (Adavin 60 mg/d)
Trial: 30541065
Drug: Losartan 50-100
RxNorm normalized name: losartan
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan 50-100 mg/d
Trial: 30541065
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil 1,400-2,800 mg/d
Trial: 29624542
Drug: Single-shot epidural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-shot epidural block with 0.25% bupivacaine plus 4 mg of morphine (10 mL) combined with general anesthesia.
Trial: 29624542
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (B and G)
Trial: 20493481
Drug: Anesthesiologist-administered sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthesiologist-administered sedation (AAS) using propofol-remifentanil (PR)
Trial: 17609490
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (6.3 g per day containing 30 mg of polyphenols)
Trial: 689746
Drug: Antibiotic decontamination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic decontamination with neomycin, polymyxin, bacitracin, and nystatin (Group A)
Trial: 31469017
Drug: Ultrasonic debridement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonic debridement plus recombinant human fibroblast growth factor (FGF) gel
Trial: 29496253
Drug: Induction radiochemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction radiochemotherapy followed by consolidation chemotherapy (arm A)
Trial: 29496253
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy followed by consolidation concurrent radiochemotherapy (arm B)
Trial: 26902765
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 0.5 g meropenem
Trial: 26902765
Drug: Intraperitoneal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal administration of 0.5 g meropenem
Trial: 20338954
Drug: Spinal analgesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal analgesia (bupivacaine 7.5 mg)
Trial: 17328965
Drug: IFN‐beta‐1a 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐beta‐1a 30 microg intramuscularly (IM) once‐weekly (qw) (n=8)
Trial: 17328965
Drug: IFN‐beta‐1a 44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐beta‐1a 44 microg subcutaneously (SC) three‐times‐weekly (tiw) (n=7)
Trial: 16353395
Drug: i.v. dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. dexamethasone (10 mg in 2 ml)
Trial: 16353395
Drug: i.v. placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. placebo (2 ml of normal saline)
Trial: 11432685
Drug: m-CPP (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-CPP (0.4 mg/kg)
Trial: 9752300
Drug: Morphine (M)
RxNorm normalized name: morphine Extended Release Oral Capsule [M-Eslon]
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (M) therapy
Trial: 9752300
Drug: No Morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Morphine (M-)
Trial: 8783312
Drug: Naloxone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (6 mg i.v.)
Trial: 31291976
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment at 'Wang's Jiaji' acupoints, five times a week for 2 weeks.
Trial: 19690559
Drug: Metformin continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin continued after switching to insulin
Trial: 11093927
Drug: DIU (diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DIU (diuretic administration; Novotriamazide; 100 mg triamterene and 50 mg hydrochlorothiazide)
Trial: 9028776
Drug: Sequential Japanese
RxNorm normalized name: Japanese encephalitis virus
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential Japanese sentences (speech)
Trial: 8174724
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (LA) 2 mg SC
Trial: 3371847
Drug: Human leukocyte
RxNorm normalized name: Human leukocyte antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human leukocyte interferon (a‐IFN) treatment at a standard i.m. dose of 0.7‐1.0 X 10(5)/kg/day for 28 consecutive days, followed by the same dose twice a week for two months.
Trial: 27550552
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered by nonclinician sleep coaches
Trial: 19347247
Drug: 42 g
RxNorm normalized name: PETROLATUM 42 g in 100 g TOPICAL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 g of protein supplement (SUP) ingested pre- and post-exercise
Trial: 7622080
Drug: Citicoline (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline (1000 mg i.m. daily for 15 days)
Trial: 1978467
Drug: Remoxipride (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride (mean daily dose 353 mg)
Trial: 1978467
Drug: Haloperidol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (mean daily dose 11 mg)
Trial: 609193
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (200 mg i.m. weekly)
Trial: 16354469
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of ofloxacin plus 600 mg of rifampicin (OR, n = 41)
Trial: 16354469
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of doxycycline plus 600 mg of rifampicin (DR, n = 45)
Trial: 16354469
Drug: 1g intramuscularly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1g intramuscularly streptomycin plus 200 mg doxycycline (DS, n = 32)
Trial: 11245347
Drug: Combination vaccine
RxNorm normalized name: Hepatitis vaccine combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination vaccine
Trial: 9855438
Drug: Separately administered
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separately administered components
Trial: 7715294
Drug: Saquinavir 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir 25 mg three times daily
Trial: 7715294
Drug: Saquinavir 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir 75 mg three times daily
Trial: 7715294
Drug: Saquinavir 200
RxNorm normalized name: saquinavir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir 200 mg three times daily
Trial: 7715294
Drug: Saquinavir 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir 600 mg three times daily
Trial: 1013853
Drug: Povidone-iodine douche
RxNorm normalized name: povidone-iodine Douche
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Povidone-iodine douche and gel
Trial: 1013853
Drug: Other methods
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other methods of vaginal preparation
Trial: 29493163
Drug: ACPV decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACPV decoction (treatment group)
Trial: 25409167
Drug: Intramuscular diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diclofenac (90 mg)
Trial: 23328126
Drug: Omega-3-Acid Ethyl
RxNorm normalized name: Omega-3-Acid Ethyl Esters
DrugBank: Omega-3-acid ethyl esters (DB09539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3-Acid Ethyl Esters (4 g/day)
Trial: 12799091
Drug: Quinapril 20
RxNorm normalized name: quinapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 20 mg/d
Trial: 15655130
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg/d
Trial: 17086021
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg/d + Quinapril 20 mg/d
Trial: 15577824
Drug: Total serum
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total serum IgE level greater than 100 IU/mL
Trial: 12033350
Drug: No antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiarrhythmic drug therapy or ICD
Trial: 2427858
Drug: Celiprolol treatment
RxNorm normalized name: celiprolol
DrugBank: Celiprolol (DB04846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol treatment
Trial: 31002317
Drug: Minimally interrupted
RxNorm normalized name: homatropine hydrobromide Ophthalmic Solution [Minims Homatropine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimally interrupted dabigatran therapy
Trial: 31002317
Drug: Uninterrupted warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uninterrupted warfarin therapy
Trial: 24048776
Drug: Symphytum herb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symphytum herb extract cream
Trial: 22691828
Drug: Tachosil® (hemostatic-sealant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tachosil® (hemostatic-sealant drug) used as a reinforcement of the suture line in sleeve gastrectomy
Trial: 7954550
Drug: Xipamide, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xipamide, 20 mg/day